Voriconazole Fresenius Kabi

Voriconazole Fresenius Kabi is an intravenous antifungal medication used to treat serious fungal infections. It belongs to the triazole class and is administered in hospital settings. This product is manufactured by Fresenius Kabi Norge As and is available in the EU.

Voriconazole is used to treat a variety of serious fungal infections, including invasive aspergillosis, candidemia, and other severe Candida infections. It may also be used to treat infections caused by Scedosporium or Fusarium species. This medication works by stopping the growth of fungi, helping the body to fight the infection more effectively.

Voriconazole works by interfering with the formation of fungal cell membranes, which weakens the fungi and makes them more susceptible to the body's immune response. Patients may experience improved symptoms as the infection begins to clear, though individual responses vary. Regular monitoring is often required during treatment.

Voriconazole should be used with caution in patients with liver or kidney problems, as it may affect these organs. Blood tests may be needed to monitor liver function during treatment. Patients should inform their healthcare provider about all medications and conditions before starting voriconazole. Avoid exposure to direct sunlight, as voriconazole can increase sensitivity to UV rays.

Voriconazole can interact with many medications, including certain antibiotics, antidepressants, and anticonvulsants. It may also interact with herbal supplements like St. John’s wort. Alcohol and grapefruit products should be avoided, as they can alter the effectiveness of voriconazole. Always consult a healthcare provider before combining medications.